

Review article. Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management
Abstract
References
Centers for Disease Control and Prevention: Inpatient Surgery. Available at http://cdc.gov/nchs/fastats/insurg.htm. Accessed June 11, 2011.
Centers for Disease Control and Prevention: U.S. Outpatient Surgeries on the Rise. Available at http://cdc.gov/nchs/pressroom/09newsreleases/outpatientsurgeries.htm. Accessed June 11, 2011.
Hopkinson JH: Hydrocodone–A unique challenge for an established drug: Comparison of repeated oral doses of hydrocodone (10 mg) and codeine (60 mg) in the treatment of postpartum pain. Curr Ther Res. 1978; 24(5): 503-516.
Eddy NB, Halbach H, Braenden OJ: Synthetic substances with morphine-like effect clinical experience: Potency, side-effects, addiction liability. Bull World Health Org. 1957; 17: 595-600.
DeNoon D: The 10 most prescribed drugs. Available at http://www.webmd.com/news/20110420/the-most-prescribeddrugs. Accessed January 28, 2013.
Nerenberg DM, Fudin J: Maximum daily dose of hydrocodone. Am J Health Syst Pharm. 2010; 67(19): 1588-1589.
Prommer E: Hydrocodone: Does it have a role in palliative care? J Opioid Manag. 2010; 6(4): 295-299.
Hydrocodone Bitartrate [product insert]. Hazelwood, MO: Mallinckrodt Inc., 2009.
US Department of Justice Drug Enforcement Administration: Controlled Substance Schedules. Available at http://www.deadiversion.usdoj.gov/schedules/index.html. Accessed September 12, 2012.
US Department of Justice Drug Enforcement Administration: Pharmacist’s Manual Section IX–Valid Prescription Requirements. Available at http://www.deadiversion.usdoj.gov/pubs/manuals/pharm2/pharm_content.htm. Accessed September 12, 2012.
Kaplan HL, Busto UE, Baylon GJ, et al.: Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability. J Pharmacol Exp Ther. 1997; 281(1): 103-108.
Cone EJ, Darwin WD, Gorodetzky CW, et al.: Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog. Drug Metab Dispos. 1979; 6(4): 488-493.
ARUP Laboratories: Drugs of Abuse-Opiates and Related Drugs. 2011. Available at www.aruplab.com/Testing-Information/resources/Technical Bulletins/drugs_of_abuse_opiates.pdf. Accessed June 2011.
Barakat NH, Atayee RS, Best BM, et al.: Relationship between the concentration of hydrocodone and its conversion to hydromorphone in chronic pain patients using urinary excretion data. J Anal Toxicol. 2012; 36(4): 257-264.
Armstrong SC, Cozza KL: Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: Theory and clinical reality, Part II. Psychosomatics. 2003; 44(6): 515-520.
Otton SV, Schadel M, Cheung SW, et al.: CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone. Clin Pharmacol Ther. 1993; 54(5): 463-472.
Hutchinson MR, Menelaou A, Foster DJ, et al.: CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes. Br J Clin Pharmacol. 2004; 57(3): 287-297.
McLellan RA, Oscarson M, Seidegard J, et al.: Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics. 1997; 7(3): 187-191.
Marco CA, Plewa MC, Buderer N, et al.: Comparison of oxycodone and hydrocodone for the treatment of acute pain associated with fractures: A double-blind, randomized, control trial. Acad Emerg Med. 2005; 12(4): 282-288.
Sunshine A, Olson NZ, O’Neill E, et al.: Analgesic efficacy of a hydrocodone with ibuprofen combination compared with ibuprofen alone for the treatment of acute postoperative pain. J Clin Pharmacol. 1997; 37(10): 908-915.
Litkowski LJ, Christensen SE, Adamson DN, et al.: Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: A randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model. Clin Ther. 2005; 27(4): 418-429.
Miner JR: Randomized double-blind placebo controlled crossover study of acetaminophen, ibuprofen, acetaminophen/hydrocodone, and placebo for the relief from a standard painful stimulus. Acad Emerg Med. 2009; 16(9): 911-914.
Rodriguez RF, Castillo JM, Castillo MP, et al.: Hydrocodone/ acetaminophen and tramadol chloral hydrate combination tablets for the management of chronic cancer pain: A double-blind comparative trial. Clin J Pain. 2008; 24(1): 1-4.
Rodriguez RF, Castillo JM, Castillo MP, et al.: Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: A 23-day, prospective, double-blind, randomized, parallel group study. Clin Ther. 2007; 29(4): 581-587.
Rodriguez RF, Bravo LE, Castro F, et al.: Incidence of weak opioids adverse events in the management of cancer pain: A doubleblind comparative trial. J Palliat Med. 2007; 10(1): 56-60.
Hewitt DJ, Todd KH, Xiang J, et al.: Tramadol/acetaminophen or hydrocodone/acetaminophen for the treatment of ankle sprain: A randomized, placebo-controlled trial. Ann Emerg Med. 2007; 49(4): 468-480.
Church CA, Stewart C IV, O-Lee TJ, et al.: Rofecoxib versus hydrocodone/acetaminophen for postoperative analgesia in functional endoscopic sinus surgery. Laryngoscope. 2006; 116(4): 602-606.
Freedman BM, Balakrishnan TP, O’Hara EL: Celecoxib reduces narcotic use and pain following augmentation mammoplasty. Aesthet Surg J. 2006; 26(1): 24-28.
Bentancourt JW, Kupp LI, Jasper SJ, et al.: Efficacy of ibuprofenhydrocodone for the treatment of postoperative pain after periodontal surgery. J Periodotol. 2004; 75(6): 872-876.
Fricke JR Jr, Karim R, Jordan D, et al.: A double-blind, single dose comparison of the analgesic efficacy of tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen combination tablets, and placebo after oral surgery. Clin Ther. 2002; 24(6): 953-968.
Palangio M, Morris E, Doyle RT Jr, et al.: Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain. Clin Ther. 2002; 24(1): 87-99.
Gimbel JS, Brugger A, Zhao W, et al.: Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ther. 2001; 23(2): 228-241.
Palangio M, Wideman GL, Keffer M, et al.: Dose-response effect of combination hydrocodone with ibuprofen in patients with moderate to severe postoperative pain. Clin Ther. 2000; 22(8): 990-1002.
Palangio M, Damask MJ, Morris E, et al.: Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain. Clin Ther. 2000; 22(7): 879-892.
Ziccardi VB, Desjardins PJ, Daly-DeJoy E, et al.: Single-dose vicoprofen compared with acetaminophen with codeine and placebo in patients with acute postoperative pain after third molar extractions. J Oral Maxillofac Surg. 2000; 58(6): 622-628.
Wideman GL, Keffer M, Morris E, et al.: Analgesic efficacy of a combination of hydrocodone with ibuprofen for postoperative pain. Clin Pharmacol Ther. 1999; 65(1): 66-76.
Barber FA, Gladu DE: Comparison of oral ketorolac and hydrocodone for pain relief after anterior cruciate ligament reconstruction. Arthroscopy. 1998; 14(6): 605-612.
Turturro MA, Paris PM, Larkin GL: Tramadol versus hydrocodone-acetaminophen in acute musculoskeletal pain: A randomized, double-blind clinical trial. Ann Emerg Med. 1998; 32(2): 139-143.
White PF, Joshi GP, Carpenter RL, et al.: A comparison of oral ketorolac and hydrocodone-acetaminophen for analgesia after ambulatory surgery: Arthroscopy versus laparoscopic tubal ligation. Anesth Analg. 1997; 85(1): 37-43.
Reed KL, Smith JR, Lie T, et al.: A pilot study comparing ketoprofen and acetaminophen with hydrocodone for the relief of postoperative periodontal discomfort. Anesth Prog. 1997; 44(2): 49-54.
Tucker PW, Smith JR, Adams DF: A comparison of 2 analgesic regimens for the control of postoperative periodontal discomfort. J Periodontol. 1996; 67(2): 125-129.
Forbes JA, Bates JA, Edquist IA, et al.: Evaluation of two opioidacetaminophen combinations and placebo in postoperative oral surgery pain. Pharmacotherapy. 1994; 14(2): 139-146.
Fricke JR, Halladay SC, Bynum L, et al.: Pain relief after dental impaction surgery using ketorolac, hydrocodone plus acetaminophen, or placebo. Clin Ther. 1993; 15(3): 500-509.
Turturro MA, Paris PM, Yealy DM, et al.: Hydrocodone versus codeine in acute musculoskeletal pain. Ann Emerg Med. 1991; 20(10): 1100-1103.
Sloan PA, Moulin D, Hays H: A clinical evaluation of TTSFentanyl for the treatment of cancer pain. J Pain Symptom Manage. 1998; 16(2): 102-111.
Sloan PA, Plymale M, LaFountain P, et al.: Equipping medial students to manage cancer pain: A comparison of three teaching educational methods among medical students. J Pain Symptom Manage. 2004; 27(4): 333-342.
Sloan PA: Review of oral oxymorphone in the management of pain. Ther Clin Risk Manag. 2008; 4(4): 777-787.
Sloan PA, Babul N: Embeda™: Morphine sulfate extended-release with sequestered naltrexone, a novel opioid formulation for the treatment of chronic pain. Int J Clin Rheumatol. 2010; 5(2): 155-164.
Morrow PL, Faris EC: Death associated with inadvertent hydrocodone overdose in a child with a respiratory tract infection. Am J Forensic Med Pathol. 1987; 8(1): 60-63.
US Food and Drug Administration: Madadi P, Hildebrandt D, Gong IY, et al.: Fatal hydrocodone overdose in a child: Pharmacogenetics and drug interactions. Pediatrics. 2010; 126(4): 986-989.
US Food and Drug Administration: Long-acting hydrocodonecontaining cough products (marketed as Tussionex® Pennkinetic Extended-Release). Available at http://www.fda.gov/ Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm091793.htm. Accessed September 12, 2012.
US Food and Drug Administration: Prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning highlight potential for severe liver failure. FDA Drug Safety Communication. Washington, DC. Available at www.fda. gov/Drugs/DrugSafety/ucm239821.htm. Accessed May 13, 2011.
Krenzelok EP: The FDA acetaminophen Advisory Committee Meeting–What is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicol. 2009; 47(8): 784-789.
Ceelie I, James LP, Gijsen V, et al.: Acute liver failure after recommended doses of acetaminophen in patients with myopathies. Crit Care Med. 2011; 39(4): 678-682.
Zogenix®: ER™ (hydrocodone bitartrate extended release). Available at http://www.zogenix.com/content/pipeline/zohydro.htm. Accessed September 12, 2012.
Sauberban JB, Anderson PO, Lane JR, et al.: Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain. Obset Gynecol. 2011; 117(3): 611-617.
Ho T, Vrabec JT, Burton AW: Hydrocodone use and sensorineural hearing loss. Pain Physician. 2007; 10(3): 467-472.
Yorgason JG, Kalinec GM, Luxford WM, et al.: Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: Evidence from two parallel in vitro mouse models. Otolaryngol Head Neck Surg. 2010; 142(6): 814-819.
Korff MV, Saunders K, Thomas Ray G, et al.: De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008; 24(6): 521-527.
Refbacks
- There are currently no refbacks.